Kaizen Clinical Services Partners with BioClinica
BioClinica, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, announced a strategic partnership with Kaizen Clinical Services, Inc., an oncologyfocused contract research organization (“CRO”).
“Our partnership will enable customers to benefit from Kaizen’s expertise in worldwide oncology trials and BioClinica’s best-in-class product suite offering,” said Peter Benton, President of the eClinical Division of BioClinica. “Kaizen’s oncology focus makes it a strong addition to the BioClinica Certified Partner Program, supporting customers in the complex therapeutic areas of study monitoring and management.”
The BioClinica Certified Partner (“BCP”) Program helps CROs address many of the complexities associated with clinical trials by leveraging the focus and the power of BioClinica software and services. BioClinica solutions enable CROs to start clinical studies more efficiently, optimize data collection, to ensure timely grants payments and track performance. BioClinica solutions provide CROs with the optimal means to more efficiently manage multiple studies with multiple sponsors and to supplement their therapeutic and clinical expertise with BioClinica’s global clinical technology support.
Kaizen Clinical Services, based in Jackson, New Jersey, is a woman-owned contract research organization that focuses on oncology trials. Founded in 2007, Kaizen offers project management, clinical monitoring, consulting and training services. The firm has managed and/or monitored Phase I through Phase IV trials that have enrolled between 35 and 2,500 patients.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
